Yicong Bian

677 total citations
28 papers, 476 citations indexed

About

Yicong Bian is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yicong Bian has authored 28 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yicong Bian's work include Drug Transport and Resistance Mechanisms (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Yicong Bian is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Yicong Bian collaborates with scholars based in China, Germany and New Zealand. Yicong Bian's co-authors include Chenrong Huang, Liyan Miao, Su Zeng, Qiuxia Chen, Linsheng Liu, Sheng Ma, Yan Wang, Lushan Yu, Haihong Hu and Donghui Pan and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Pharmaceutics and Journal of Ethnopharmacology.

In The Last Decade

Yicong Bian

25 papers receiving 469 citations

Peers

Yicong Bian
Hong Seok Choi South Korea
Xiaoli Song China
Rong Zhu China
Kiichi Matsuyama Japan
Qinghong Qin China
Erhan Onuk Türkiye
Takeshi Kotake Japan
Sabah H. El-Ghaiesh Saudi Arabia
Hong Seok Choi South Korea
Yicong Bian
Citations per year, relative to Yicong Bian Yicong Bian (= 1×) peers Hong Seok Choi

Countries citing papers authored by Yicong Bian

Since Specialization
Citations

This map shows the geographic impact of Yicong Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yicong Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yicong Bian more than expected).

Fields of papers citing papers by Yicong Bian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yicong Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yicong Bian. The network helps show where Yicong Bian may publish in the future.

Co-authorship network of co-authors of Yicong Bian

This figure shows the co-authorship network connecting the top 25 collaborators of Yicong Bian. A scholar is included among the top collaborators of Yicong Bian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yicong Bian. Yicong Bian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Meng, Chao Wang, Yicong Bian, et al.. (2024). Human dose-escalation study of PET imaging CD8+ T-cell infiltration in solid malignancies with [68Ga]Ga -NODAGA-SNA006. European Journal of Nuclear Medicine and Molecular Imaging. 52(4). 1332–1344. 2 indexed citations
2.
3.
4.
Ma, Sheng, Ling Yi, Yicong Bian, et al.. (2024). Absorption, metabolism, and excretion of oral [14C] radiolabeled donafenib: an open-label, phase I, single-dose study in humans. Cancer Chemotherapy and Pharmacology. 95(1). 5–5. 2 indexed citations
5.
Bian, Yicong, Sheng Ma, Wei Chen, et al.. (2023). Pharmacokinetics, Mass Balance and Metabolism of [14C]HSK21542, a Novel Kappa Opioid Receptor Agonist, in Humans. European Journal of Drug Metabolism and Pharmacokinetics. 48(6). 723–731. 4 indexed citations
6.
Zhang, Hua, Shu Yan, Sheng Ma, et al.. (2023). A mass balance study of [14C]SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humans. Frontiers in Pharmacology. 14. 1116073–1116073. 5 indexed citations
7.
Bian, Yicong, et al.. (2022). Is Monitoring of the Intracellular Active Metabolite Levels of Nucleobase and Nucleoside Analogs Ready for Precision Medicine Applications?. European Journal of Drug Metabolism and Pharmacokinetics. 47(6). 761–775. 2 indexed citations
8.
Wang, Yan, Chao Wang, Shibiao Sang, et al.. (2022). Pilot study of a novel nanobody 68 Ga-NODAGA-SNA006 for instant PET imaging of CD8+ T cells. European Journal of Nuclear Medicine and Molecular Imaging. 49(13). 4394–4405. 26 indexed citations
9.
Bian, Yicong, Hua Zhang, Dong Tang, et al.. (2021). The metabolism and excretion of the dipeptidyl peptidase 4 inhibitor [14C] cetagliptin in healthy volunteers. Xenobiotica. 52(1). 38–45. 4 indexed citations
10.
Wang, Yan, Haiqing Ni, Shuaixiang Zhou, et al.. (2020). Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity. Cancer Immunology Immunotherapy. 70(2). 365–376. 87 indexed citations
11.
Zhang, Hua, Yicong Bian, Sheng Ma, et al.. (2020). Pharmacokinetics, mass balance, and metabolism of [14C]vicagrel, a novel irreversible P2Y12 inhibitor in humans. Acta Pharmacologica Sinica. 42(9). 1535–1546. 19 indexed citations
12.
Xu, Qingqing, et al.. (2020). Effect of Green Tea and (-)-Epigallocatechin Gallate on the Pharmacokinetics of Rosuvastatin. Current Drug Metabolism. 21(6). 471–478. 7 indexed citations
13.
Huang, Chenrong, Fan Xia, Ling Xue, et al.. (2019). Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3. Cancer Chemotherapy and Pharmacology. 85(2). 433–441. 12 indexed citations
14.
Cao, Jun, Cuilin Shi, Yicong Bian, et al.. (2018). First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform. Biochemical and Biophysical Research Communications. 497(2). 485–491. 40 indexed citations
15.
Liu, Linsheng, Chenrong Huang, Yicong Bian, & Liyan Miao. (2017). GC-MS based metabolomics of CSF and blood serum: Metabolic phenotype for a rat model of cefoperazone-induced disulfiram-like reaction. Biochemical and Biophysical Research Communications. 490(3). 1066–1073. 2 indexed citations
16.
Tian, Ye, et al.. (2015). Interplay of Breast Cancer Resistance Protein (BCRP) and Metabolizing Enzymes. Current Drug Metabolism. 16(10). 877–893. 9 indexed citations
17.
Bian, Yicong, Qingqing Yao, Haitao Shang, et al.. (2015). Expression of Bama Minipig and Human CYP3A Enzymes: Comparison of the Catalytic Characteristics with Each Other and Their Liver Microsomes. Drug Metabolism and Disposition. 43(9). 1336–1340. 12 indexed citations
18.
Ma, Liping, Lei Zhao, Haihong Hu, et al.. (2014). Interaction of five anthraquinones from rhubarb with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8) and drug–drug interaction in rats. Journal of Ethnopharmacology. 153(3). 864–871. 50 indexed citations
19.
Chen, Qiuxia, Yicong Bian, & Su Zeng. (2013). Involvement of AP-1 and NF-κB in the Up-regulation of P-gp in Vinblastine Resistant Caco-2 Cells. Drug Metabolism and Pharmacokinetics. 29(2). 223–226. 39 indexed citations
20.
Hu, Haihong, Yicong Bian, Yao Liu, et al.. (2013). Evaluation of blood–brain barrier and blood–cerebrospinal fluid barrier permeability of 2-phenoxy-indan-1-one derivatives using in vitro cell models. International Journal of Pharmaceutics. 460(1-2). 101–107. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Seok Choi Breakdown of academic impact, for papers by Xiaoli Song Breakdown of academic impact, for papers by Rong Zhu Breakdown of academic impact, for papers by Kiichi Matsuyama Breakdown of academic impact, for papers by Qinghong Qin Breakdown of academic impact, for papers by Erhan Onuk Breakdown of academic impact, for papers by Takeshi Kotake Breakdown of academic impact, for papers by Sabah H. El-Ghaiesh
Rankless by CCL
2026